HALO logo
7V0
Novogenia AG

7V0 · Novogenia AG

6.40

EUR
-0.25 (-3.759%)
16/10/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro79.80M

PE

84.70

EV/EBITDA

N/A

DIV Yield

7.3%

Payout Ratio

200%

MQV Rating

5Very Weak

As at 16/10/2026 12:00:00 AM

Price Chart

Description

Novogenia AG engages in the analysis of genetic materials and provides related research and development, as well as consulting services. The firm also focuses on the development, manufacture, and sale of genetically personalized products such as food supplements and cosmetics. The company was founded by Daniel Wallerstorfer on March 15, 2021 and is headquartered in Munich, Germany.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • HALO All
  • HALO Consensus Value
  • HALO Small

Key Fundamentals

EPS 3 yr Growth

-97.60%

EBITDA Margin

-13.50%

Operating Cashflow

-€13m

Free Cash Flow Return

-11.90%

ROIC

1.00%

Interest Coverage

-13.40

Quick Ratio

5.10

Performance

52 weeks range

Low 5.75 - 11.9

Trade Value (12mth)

US$5,217.00

1 week

3.17%

1 month

-7.8%

YTD

-15.03%

1 year

-17.72%

All time high

11.90

Additional Data

Shares Outstanding (Fully Diluted)

12m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

29-Jun-26

Next Dividend Pay Date

01-Jul-26

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and model portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Novogenia AG (7V0:ETR)?
Halo FAQ
The current share price of Novogenia AG (7V0:ETR) is EUR€6.40.
2
What is the 52-week high share price for Novogenia AG (7V0:ETR)?
Halo FAQ
The 52-week high share price for Novogenia AG (7V0:ETR) is EUR€11.90.
3
What is the 52-week low share price for Novogenia AG (7V0:ETR)?
Halo FAQ
The 52-week low share price for Novogenia AG (7V0:ETR) is EUR€5.75.
4
What is the dividend yield for Novogenia AG (7V0:ETR)?
Halo FAQ
The current TTM dividend payout for Novogenia AG (7V0:ETR) is 7.30.
5
What was Novogenia AG (7V0:ETR) last dividend payment?
Halo FAQ
The last dividend payment of Novogenia AG (7V0:ETR) is EUR€0.56.
6
What is the franking level for Novogenia AG (7V0:ETR)?
Halo FAQ
Novogenia AG (7V0:ETR) has a franking level of 0.00%.
7
In which sector is Novogenia AG (7V0:ETR) classified?
Halo FAQ
Novogenia AG (7V0:ETR) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Novogenia AG (7V0:ETR)?
Halo FAQ
The current P/E ratio for Novogenia AG (7V0:ETR) is 84.70.